ArticleMolecular psychiatry2016
Gene expression in major depressive disorder.
Article in Molecular psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.Nature communications · 2017Trial
- Immuno-metabolic depression: from concept to implementation.The Lancet regional health. Europe · 2025Review
- Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress.Frontiers in pharmacology · 2024Article
- Gene expression and brain imaging association study reveals gene signatures in major depressive disorder.Brain communications · 2024Article
- Glial immune-related pathways mediate effects of closed head traumatic brain injury on behavior and lethality in Drosophila.PLoS biology · 2022Article
- Integration of GWAS and brain eQTL identifies FLOT1 as a risk gene for major depressive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019Article
- Multi-tissue transcriptome analyses identify genetic mechanisms underlying neuropsychiatric traits.Nature genetics · 2019Article
- Depression and obesity: evidence of shared biological mechanisms.Molecular psychiatry · 2019Review
- Dvl3 polymorphism interacts with life events and pro-inflammatory cytokines to influence major depressive disorder susceptibility.Scientific reports · 2018Article
- Identification and replication of RNA-Seq gene network modules associated with depression severity.Translational psychiatry · 2018Article
- Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis.Experimental & molecular medicine · 2018Article
- Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder.Biological psychiatry · 2018Article
- Identification of IL6 as a susceptibility gene for major depressive disorder.Scientific reports · 2016Article
- Serum proteomic profiles of depressive subtypes.Translational psychiatry · 2016Article
- Role of neuro-immunological factors in the pathophysiology of mood disorders.Psychopharmacology · 2016Review
- Systems Genomics Support for Immune and Inflammation Hypothesis of Depression.Current neuropharmacology · 2016Review
Corrections and comments
- Erratum for
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
26100536What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.